BridgeBio Oncology Therapeutics
Price & Volume
Stats
See more52W Range | $8.58-$14.87 |
Market Cap | $1B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.11 |
News
See moreYahoo Finance • 9 days ago
BBOT Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026
Yahoo Finance • 11 days ago
Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch
Yahoo Finance • 21 days ago
BBOT Announces Publication in Cancer Discovery Highlighting Preclinical Data Demonstrating BBO-11818 is a Potent and Selective panKRAS Inhibitor
Yahoo Finance • 3 months ago
Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million?
About
CEO | Mr. Eli M. Wallace Ph.D. |
Address | 256 East Grand Avenue, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 92 |
